Bright Minds Biosciences
$65.79
75
+$2.15+3.38% Friday 20:00
+$0.01+0.02%Friday 23:28After hours
Statistics
Day High
66.18
Day Low
65.64
52W High
123.75
52W Low
23.18
Volume
5,496
Avg. Volume
-
Mkt Cap
512.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13AugExpected
Expected EPS
-1.283121
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-17.59MNet Income
Analyst Ratings
147.40Average Price Target
The highest estimate is 220.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DRUG. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Jazz Pharmaceuticals
JAZZ
Mkt Cap14.11B
Acadia Pharmaceuticals
ACAD
Mkt Cap3.7B
Alkermes
ALKS
Mkt Cap7.67B
BridgeBio Pharma
BBIO
Mkt Cap12.98B
Corbus Pharmaceuticals
CRBP
Mkt Cap153.04M
Neurocrine Biosciences
NBIX
Mkt Cap15.92B
PTC Therapeutics
PTCT
Mkt Cap6.72B
About
Bright Minds Biosciences Inc. is a preclinical biotechnology firm dedicated to creating serotonin-based therapies. Its primary goal is to enhance the well-being of individuals suffering from severe and life-altering conditions. The company's development pipeline includes selective agonists for the 5-HT2C, 5-HT2A, and combined 5-HT2C/A serotonin receptors, which are being explored for potential treatments in epilepsy, pain management, and neuropsychiatric disorders. Bright Minds maintains strategic collaborations with the National Institutes of Health (NIH) for epilepsy research, the University of Texas Medical Branch (UTMB) for impulse control disorders like binge eating, and the Medical College of Wisconsin. The company, incorporated in 2019, operates from its headquarters in Vancouver, Canada.
Show more...
CEO
Mr. Ian McDonald
Employees
26
Country
Canada
ISIN
CA10919W4056
Listings
0 Comments
Share your thoughts
FAQ
What is Bright Minds Biosciences stock price today?▼
The current price of DRUG is $65.79 USD — it has increased by +3.38% in the past 24 hours. Watch Bright Minds Biosciences stock price performance more closely on the chart.
What is Bright Minds Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bright Minds Biosciences stocks are traded under the ticker DRUG.
Is Bright Minds Biosciences stock price growing?▼
DRUG stock has risen by +8.46% compared to the previous week, the month change is a -24.41% fall, over the last year Bright Minds Biosciences has showed a +182.72% increase.
What is Bright Minds Biosciences market cap?▼
Today Bright Minds Biosciences has the market capitalization of 512.31M
When is the next Bright Minds Biosciences earnings date?▼
Bright Minds Biosciences is going to release the next earnings report on August 13, 2026.
What were Bright Minds Biosciences earnings last quarter?▼
DRUG earnings for the last quarter are -0.79 USD per share, whereas the estimation was -0.86 USD resulting in a +8.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bright Minds Biosciences revenue for the last year?▼
Bright Minds Biosciences revenue for the last year amounts to 0 USD.
What is Bright Minds Biosciences net income for the last year?▼
DRUG net income for the last year is -17.59M USD.
How many employees does Bright Minds Biosciences have?▼
As of June 27, 2026, the company has 26 employees.
In which sector is Bright Minds Biosciences located?▼
Bright Minds Biosciences operates in the Health & Wellness sector.
When did Bright Minds Biosciences complete a stock split?▼
The last stock split for Bright Minds Biosciences was on July 14, 2023 with a ratio of 1:5.
Where is Bright Minds Biosciences headquartered?▼
Bright Minds Biosciences is headquartered in New York, Canada.